SACHDEV AMIT (EVP, CRO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/26/2026ACC: 0000875320-26-000024
Officer· EVP, CRO
Since Jun 2018
+11.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
11.75K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.87K
Price / share
—
Trade value
—
% of position
13.3%
1/22/2026
59.25K→67.11K
Common Stock
Direct
Shares
+3.88K
Price / share
—
Trade value
—
% of position
5.8%
1/22/2026
67.11K→71K
Total
Net shares
+11.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | A · Award | +7.87K | — | — | 13.3% | 59.25K | 67.11K |
| Common Stock Direct | 1/22/2026 | A · Award | +3.88K | — | — | 5.8% | 67.11K | 71K |
| Total | +11.75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned882.00
Common Stock
IndirectShares owned9.30K
Total
10.18K indirect10.18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 882.00 | Indirect |
| Common Stock | 9.30K | Indirect |
| Total | 10.18K | 10.18K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported